HomePMCB • NASDAQ
add
Pharmacyte Biotech Inc
Previous close
$1.72
Day range
$1.66 - $1.80
Year range
$1.39 - $2.58
Market cap
13.13M USD
Avg Volume
43.00K
P/E ratio
3.42
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jul 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.27M | -38.86% |
Net income | 23.42M | 835.76% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jul 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 32.64M | -56.29% |
Total assets | 70.19M | -12.13% |
Total liabilities | 17.15M | -15.90% |
Total equity | 53.04M | — |
Shares outstanding | 7.68M | — |
Price to book | 0.28 | — |
Return on assets | -4.88% | — |
Return on capital | -6.45% | — |
Cash Flow
Net change in cash
| (USD) | Jul 2024info | Y/Y change |
|---|---|---|
Net income | 23.42M | 835.76% |
Cash from operations | -373.30K | -208.85% |
Cash from investing | -7.00M | — |
Cash from financing | -10.17M | -261.99% |
Net change in cash | -17.54M | -364.92% |
Free cash flow | 5.33M | 1,638.95% |
About
Founded
1996
Headquarters
Website
Employees
2
